OXYPOINT
Curator
the curator has managed the company since 11-12-2025Last board
4 directors, 2 in day-to-day management, 1 auditor, last change in 2025Independent director and day-to-day manager, permanent representative Frank Pieters
independent director since 21-01-2022
day-to-day manager appointed by deed of 10-03-2025
term until 01-06-2027
listed in the 2024 annual accounts, filed on 15-07-2025
Director and day-to-day manager, permanent representative Guy Lefever
director current term since 03-06-2022
day-to-day manager appointed by deed of 10-03-2025
term until 01-06-2027
listed in the 2024 annual accounts, filed on 15-07-2025
Innovamus BV
Director, permanent representative Philip Hendrickx
in office according to the deed of 10-03-2025
earlier bestuurder belast met dagelijks bestuur, until 29-08-2024
Statutory auditor, permanent representative Philippe VENKEN
appointed by deed of 07-02-2022
- P&L Projects BV, Startegica BV
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- “Artikel 22: Vertegenwoordiging van de vennootschap 22.1. De raad van bestuur vertegenwoordigt de vennootschap jegens derden en in rechte als…”deed of 11-05-2022
Permanent representatives 4
Philip Hendrickx
Permanent representative, for Innovamus BV
in office according to the deed of 10-03-2025
Mandates through the years
12 names, the dashed line is todayInnovamus BV
Director
Director
P&L Projects BV
Independent director, Day-to-day manager
Independent director, Day-to-day manager
Startegica BV
Director, Day-to-day manager
Director, Day-to-day manager
GEO-PHARM
Director
Director
BDO BEDRIJFSREVISOREN-BDO REVISEURS D'ENTREPRISES
Statutory auditor
Statutory auditor
COFIMA S.A.
Director
Director
Dirk Borgonjon
Director
Director
Participatiemaatschappij Vlaanderen
Class A director
Class A director
Wouter Van Roost
Day-to-day manager
Day-to-day manager
HANSEN Luc Colette Alexandre
Director
Director
OPIGO!
Director
Director
David Devigne
Director
Director
LeadershipBoardEarliermandate already running before its first mentionBankruptcy 11-12-2025
Mandates as a list
- Innovamus BV
- Director, from 23-03-2018, until the bankruptcy of 11-12-2025
- CEO, appointed by deed of 07-02-2022, until 29-08-2024
- P&L Projects BV
- Independent director, from before 31-12-2021, until the bankruptcy of 11-12-2025
- Day-to-day manager, appointed by deed of 10-03-2025, until the bankruptcy of 11-12-2025
- Startegica BV
- Director, appointed by deed of 11-05-2022, until the bankruptcy of 11-12-2025
- Day-to-day manager, appointed by deed of 10-03-2025, until the bankruptcy of 11-12-2025
- GEO-PHARM
- Director, appointed by deed of 10-03-2025, until the bankruptcy of 11-12-2025
- BDO BEDRIJFSREVISOREN-BDO REVISEURS D'ENTREPRISES
- Statutory auditor, from 21-01-2022, until the bankruptcy of 11-12-2025
- COFIMA S.A.
- Director, from 25-05-2021 to 28-06-2024
- Dirk Borgonjon
- Director, from 26-10-2020 to 11-05-2022
- Participatiemaatschappij Vlaanderen
- Class A director, appointed by deed of 29-04-2020, until 11-05-2022
- Wouter Van Roost
- Day-to-day manager, until 01-10-2021
- HANSEN Luc Colette Alexandre
- Director, until 16-06-2021
- OPIGO!
- Director, from 26-10-2020 to 26-12-2020
- David Devigne
- Director, until 30-03-2020
Control
Shareholder
Equity €4.18bn
Profit €17.2m in 2025 (profit €27.2m in 2024)
26.13%
This company
OXYPOINT
Equity -€747,099
Loss €624,006 in 2024
Capital
- Capital
- €1,325,472.92
- Shares
- 200
- Contribution per share
- €6,627
- Equity per share
- -€3,735 in 2024
- Source
- 2024 annual accounts
Owners through the years
as the annual accounts name themOwners as a list
- Participatiemaatschappij Vlaanderen
Source: lists of holdings in the owners' accounts
Articles of association
deed of 11-05-2022 (in Dutch)- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 2 directorsAt most 6 directors“Raad van bestuur, ten hoogste zes jaar”
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- “Artikel13:Overdracht van aandelen onder de levenden”“Alle Effecten onderzelfde voorwaarden en modaliteiten, voor Volgplicht Overdracht stemmen”“Schriftelijk, Kennisgeving Volgplicht”“Onherroepelijke volmacht, handelingen stellen en documenten ondertekenen en afleveren voor Volgplicht Overdracht en Overdracht van alle…”“13.6.4, Volgplicht primeert op Voorkooprecht en Volgrecht”
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- First Monday of June at 15:00
Capital transactions
Shareholders according to the deeds
After 9 capital increases
deed of 11-05-2022 ↗
- Factor Plus (BE 0826.424.558)
Capital over time
- 11-05-2022 Incorporation · €20,000 · 200 shares
- 11-05-2022 Capital increase of €100,500 · to €120,500 · 67 new shares at €1,500 per share
- 11-05-2022 Capital increase of €2,477.70 · to €122,977.70 · 549 new shares · in cash
- 11-05-2022 Capital increase of €67,432.41 · to €190,410.11 · no new shares · “omzetting in kapitaal afgenomen van rekening Uitgiftepremies”
- 11-05-2022 Capital increase of €125,127.13 · to €315,537.24 · 17,906 new shares
- 11-05-2022 Capital increase of €2,154,872.87 · to €2,470,410.11 · no new shares · “omzetting in kapitaal afgenomen van rekening Uitgiftepremies”
- 11-05-2022 Capital increase of €257,793.52 · to €2,728,203.63 · 4,712 new shares
- 11-05-2022 Capital increase of €342,206.48 · to €3,070,410.11 · no new shares · “omzetting in kapitaal afgenomen van rekening Uitgiftepremies”
Show 9 older capital entries
- 11-05-2022 Capital reduction of €891,413.68 · to €2,178,996.43 · “aanzuivering van totaliteit van geleden verliezen per 2018-12-31”
- 11-05-2022 Capital increase of €315,688.80 · to €2,494,685.23 · 7,224 new shares
- 11-05-2022 Capital increase of €604,311.20 · to €3,098,996.43 · no new shares · “omzetting in kapitaal afgenomen van rekening Uitgiftepremies”
- 11-05-2022 Capital reduction of €1,257,611.37 · to €1,841,385.06 · “aanzuivering van geleden verliezen per 2020-12-31”
- 11-05-2022 Capital reduction of €515,912.14 · to €1,325,472.92 · “aanzuivering van geleden verliezen per 2021-12-31”
- 11-05-2022 Capital reduction of €515,912.14 · to €1,325,472.92 · aanzuivering geleden verliezen per 2021-12-31
- 16-06-2021 Capital reduction of €1,257,611.37 · to €1,841,385.06 · “aanzuivering van de geleden verliezen per 2020-12-31”
- 29-04-2020 Capital increase of €315,688.80 · to €2,494,685.23 · 7,224 new shares
- 29-04-2020 Capital increase of €604,311.20 · to €3,098,996.43 · no new shares · “omzetting in kapitaal van bedrag afgenomen van rekening "Uitgiftepremies"”